GENNA THOMPSON: Open Payments
NPI 1003401563 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 85 payments from 13 companies in 2025. Trend: 2023 $1,403 · 2024 $1,606 · 2025 $2,286
Food & beverage: $2,286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $479 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $472 |
| Neurocrine BioSciences, Inc. | 13 | $283 |
| Indivior Inc. | 6 | $158 |
| Alkermes, Inc. | 7 | $152 |
| Teva Pharmaceuticals USA, Inc. | 5 | $148 |
| TREACE MEDICAL CONCEPTS, INC. | 1 | $140 |
| E.R. Squibb & Sons, L.L.C. | 5 | $135 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 5 | $124 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, SUBLOCADE, ARISTADA, AUSTEDO XR, COBENFY, Auvelity.
Industry payments across CT — which companies pay providers there.
